BioVaxys (Amendment to Asset Purchase Agreement)
Funding Details
- Awarder
- RSS - www.prnewswire.com
- Date Award
- May 30, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Company Description
- BioVaxys is a biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases.
- Market
- Healthcare
- Location
- USA